Literature DB >> 22637476

Mechanism for p38α-mediated experimental autoimmune encephalomyelitis.

Kana Namiki1, Hirofumi Matsunaga, Kento Yoshioka, Kensuke Tanaka, Kazuya Murata, Junji Ishida, Akira Sakairi, Jundal Kim, Naoki Tokuhara, Nobuhiko Shibakawa, Motohisa Shimizu, Yukinori Wada, Yasunori Tokunaga, Manabu Shigetomi, Masahiko Hagihara, Sadao Kimura, Tatsuhiko Sudo, Akiyoshi Fukamizu, Yoshitoshi Kasuya.   

Abstract

One of the mitogen-activated protein kinases, p38, has been found to play a crucial role in various inflammatory responses. In this study, we analyzed the roles of p38α in multiple sclerosis, using an animal model, experimental autoimmune encephalomyelitis (EAE). p38α(+/-) mice (p38α(-/-) showed embryonic lethality) showed less severe neurological signs than WT mice. Adoptive transfer of lymph node cells (LNC) from sensitized WT mice with MOG(35-55) to naive WT-induced EAE was much more severe compared with the case using LNC from sensitized p38α(+/-) mice. Comprehensive analysis of cytokines from MOG(35-55)-challenged LNC by Western blot array revealed that production of IL-17 was significantly reduced by a single copy disruption of the p38α gene or a p38 inhibitor. Likewise, by a luciferase reporter assay, an electrophoresis mobility shift assay, and characterization of the relationship between p38 activity and IL-17 mRNA expression, we confirmed that p38 positively regulates transcription of the Il17 gene. Furthermore, oral administration of a highly specific p38α inhibitor (UR-5269) to WT mice at the onset of EAE markedly suppressed the progression of EAE compared with a vehicle group. These results suggest that p38α participates in the pathogenesis of EAE through IL-17 induction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22637476      PMCID: PMC3397849          DOI: 10.1074/jbc.M111.338541

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

Review 1.  Are current disease-modifying therapeutics in multiple sclerosis justified on the basis of studies in experimental autoimmune encephalomyelitis?

Authors:  Nasr Farooqi; Bruno Gran; Cris S Constantinescu
Journal:  J Neurochem       Date:  2010-10-07       Impact factor: 5.372

2.  N-type calcium channel in the pathogenesis of experimental autoimmune encephalomyelitis.

Authors:  Naoki Tokuhara; Kana Namiki; Mai Uesugi; Chihiro Miyamoto; Makoto Ohgoh; Katsutoshi Ido; Takashi Yoshinaga; Toshihiko Yamauchi; Junro Kuromitsu; Sadao Kimura; Norimasa Miyamoto; Yoshitoshi Kasuya
Journal:  J Biol Chem       Date:  2010-08-18       Impact factor: 5.157

Review 3.  Emerging roles of ATF2 and the dynamic AP1 network in cancer.

Authors:  Pablo Lopez-Bergami; Eric Lau; Ze'ev Ronai
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

4.  Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse.

Authors:  H H Wang; Y Q Dai; W Qiu; Z Q Lu; F H Peng; Y G Wang; J Bao; Y Li; X Q Hu
Journal:  J Clin Neurosci       Date:  2011-07-26       Impact factor: 1.961

5.  Role of SMAD and non-SMAD signals in the development of Th17 and regulatory T cells.

Authors:  Ling Lu; Julie Wang; Feng Zhang; Yang Chai; David Brand; Xuehao Wang; David A Horwitz; Wei Shi; Song Guo Zheng
Journal:  J Immunol       Date:  2010-03-19       Impact factor: 5.422

6.  p38{alpha} MAP kinase controls IL-17 synthesis in vogt-koyanagi-harada syndrome and experimental autoimmune uveitis.

Authors:  Alessandra Gonçalves Commodaro; Cíntia Raquel Bombardieri; Jean Pierre Schatzmann Peron; Kelly Cristina Saito; Pedro Mancini Guedes; Dânia E Hamassaki; Rubens N Belfort; Luiz Vicente Rizzo; Rubens Belfort; Maristela Martins de Camargo
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-02-17       Impact factor: 4.799

7.  Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis.

Authors:  Gurumoorthy Krishnamoorthy; Amit Saxena; Lennart T Mars; Helena S Domingues; Reinhard Mentele; Avraham Ben-Nun; Hans Lassmann; Klaus Dornmair; Florian C Kurschus; Roland S Liblau; Hartmut Wekerle
Journal:  Nat Med       Date:  2009-06       Impact factor: 53.440

8.  The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation.

Authors:  Muhammet F Gulen; Zizhen Kang; Katarzyna Bulek; Wan Youzhong; Tae Whan Kim; Yi Chen; Cengiz Z Altuntas; Kristian Sass Bak-Jensen; Mandy J McGeachy; Jeong-Su Do; Hui Xiao; Greg M Delgoffe; Booki Min; Jonathan D Powell; Vincent K Tuohy; Daniel J Cua; Xiaoxia Li
Journal:  Immunity       Date:  2010-01-07       Impact factor: 31.745

9.  Signaling via the kinase p38α programs dendritic cells to drive TH17 differentiation and autoimmune inflammation.

Authors:  Gonghua Huang; Yanyan Wang; Peter Vogel; Thirumala-Devi Kanneganti; Kinya Otsu; Hongbo Chi
Journal:  Nat Immunol       Date:  2012-01-08       Impact factor: 25.606

10.  Regulation of the severity of neuroinflammation and demyelination by TLR-ASK1-p38 pathway.

Authors:  Xiaoli Guo; Chikako Harada; Kazuhiko Namekata; Atsushi Matsuzawa; Monsterrat Camps; Hong Ji; Dominique Swinnen; Catherine Jorand-Lebrun; Mathilde Muzerelle; Pierre-Alain Vitte; Thomas Rückle; Atsuko Kimura; Kuniko Kohyama; Yoh Matsumoto; Hidenori Ichijo; Takayuki Harada
Journal:  EMBO Mol Med       Date:  2010-12       Impact factor: 12.137

View more
  21 in total

1.  Sex-specific control of central nervous system autoimmunity by p38 mitogen-activated protein kinase signaling in myeloid cells.

Authors:  Dimitry N Krementsov; Rajkumar Noubade; Julie A Dragon; Kinya Otsu; Mercedes Rincon; Cory Teuscher
Journal:  Ann Neurol       Date:  2014-01       Impact factor: 10.422

Review 2.  The emerging role of p38 mitogen-activated protein kinase in multiple sclerosis and its models.

Authors:  Dimitry N Krementsov; Tina M Thornton; Cory Teuscher; Mercedes Rincon
Journal:  Mol Cell Biol       Date:  2013-07-29       Impact factor: 4.272

3.  Administration of SB203580, a p38 MAPK Inhibitor, Reduced the Expression of MMP9, and Relieved Neurologic Severity in the Experimental Autoimmune Neuritis (EAN) in Rats.

Authors:  Yanyan Sun; Hongping Chen; Shuainan Ma; Lixin Liang; Yi Zheng; Xiao Guo; Mingfei Wang; Wei Wang; Guozhong Li; Di Zhong
Journal:  Neurochem Res       Date:  2015-05-22       Impact factor: 3.996

4.  Celastrol suppresses experimental autoimmune encephalomyelitis via MAPK/SGK1-regulated mediators of autoimmune pathology.

Authors:  Shivaprasad H Venkatesha; Kamal D Moudgil
Journal:  Inflamm Res       Date:  2019-02-28       Impact factor: 4.575

5.  The p38α MAPK Deletion in Oligodendroglia does not Attenuate Myelination Defects in a Mouse Model of Periventricular Leukomalacia.

Authors:  Seung H Chung; Sangita Biswas; Jiho Sohn; Peng Jiang; Samaneh Dehghan; Hassan Marzban; Wenbin Deng
Journal:  Neuroscience       Date:  2018-07-05       Impact factor: 3.590

6.  The sex-specific role of p38 MAP kinase in CNS autoimmunity is regulated by estrogen receptor alpha.

Authors:  Mahalia M McGill; Bristy Sabikunnahar; Qian Fang; Cory Teuscher; Dimitry N Krementsov
Journal:  J Neuroimmunol       Date:  2020-03-04       Impact factor: 3.478

7.  p38α controls self-renewal and fate decision of neurosphere-forming cells in adult hippocampus.

Authors:  Kento Yoshioka; Kana Namiki; Tatsuhiko Sudo; Yoshitoshi Kasuya
Journal:  FEBS Open Bio       Date:  2015-05-08       Impact factor: 2.693

8.  The p38 mitogen-activated protein kinase cascade modulates T helper type 17 differentiation and functionality in multiple sclerosis.

Authors:  Diletta Di Mitri; Manolo Sambucci; Maria Loiarro; Marco De Bardi; Elisabetta Volpe; Maria Teresa Cencioni; Claudio Gasperini; Diego Centonze; Claudio Sette; Arne N Akbar; Giovanna Borsellino; Luca Battistini
Journal:  Immunology       Date:  2015-07-06       Impact factor: 7.397

9.  Go-sha-jinki-Gan Alleviates Inflammation in Neurological Disorders via p38-TNF Signaling in the Central Nervous System.

Authors:  Shiying Jiang; Kousuke Baba; Keisuke Hagihara; Hideki Mochizuki; Tatsusada Okuno; Makoto Kinoshita; Chi-Jing Choong; Hideki Hayakawa; Hiroshi Sakiyama; Kensuke Ikenaka; Seiichi Nagano; Tsutomu Sasaki; Munehisa Shimamura; Yoshitaka Nagai
Journal:  Neurotherapeutics       Date:  2020-10-20       Impact factor: 7.620

10.  Bidirectional role of IL-6 signal in pathogenesis of lung fibrosis.

Authors:  Takeshi Kobayashi; Kensuke Tanaka; Tetsuo Fujita; Hiroki Umezawa; Hiroyuki Amano; Kento Yoshioka; Yusuke Naito; Masahiko Hatano; Sadao Kimura; Koichiro Tatsumi; Yoshitoshi Kasuya
Journal:  Respir Res       Date:  2015-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.